1PROMRAT K, LUTCHMAN G, UWAIFO G I, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis[J]. Hepatology, 2004, 39 (1) : 188- 196. 被引量：1
3DE TAEYE B M, NOVITSKAYA T, MCGUINNESS O P, et al. Macrophage TNF-alpha contribu tes to insulin resistance and hepatic steatosis in diet - induced obesity [ J ]. Am J Physiol Endocrinol Metab, 2007, 293 (3) : E713-E725. 被引量：1
4GARCIA-RUIZ I, RODRIGUEZ-JUAN C, DIAZ-SANJUAN T, et al. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice [ J ]. Hepatology, 2006, 44 (3): 581-591. 被引量：1
5TOKUSHIGE K, TAKAKURA M, TSUCHIYA-MATSUSHITA N, et al. Influence of TNF gene polymor- phisms in Japanese patients with NASH and simple steatosis[J]. J Hepatol, 2007, 46 (6): 1104-1110. 被引量：1
6VALENTI L, FRACANZANI A L, DONGIOVANNI P, et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease[J]. Gastroenterology, 2002, 122 (2): 274- 280. 被引量：1
7ALWAYN I P, ANDERSSON C, LEE S, et al. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model[ J]. Am J Physiol Gastrointest Liver Physiol, 2006, 291 (6) : G1011-G1019. 被引量：1
9LUTCHMAN G, PROMRAT K, KLEINER D E, et al. Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement[J]. Clin Gastroenterol Hepatol, 2006, 4 (8): 1048-1052. 被引量：1
1Jian-Gao Fan~1 Liang-Hua Chen~2 Zheng-Jie Xu~1 Min-De Zeng~3 1 Department of Gastroenterology,Shanghai First People’s Hospital,Shanghai 200085,China2 Department of Cardiology,Shandong Provincial Hospital,Jinan 250021,China3 Shanghai Institute of Digestive Diseases,Shanghai 200080,China.Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver[J].World Journal of Gastroenterology,2001,7(5):710-712. 被引量：8
7WELLEN K E,HOTAMISLIGIL G S.Obesity-induced inflammatory changes in adipose tissue[J].J Clin Invest,2003,112 (12):1785-1788. 被引量：1
8DANDONA P,ALJADA A,MOHANTY P,et al.Insulin inhibits intranuclear nuclear factor kappa B and stimulates I-kappa B in mononuclear cells in obese subjects:evidence for an anti-inflammatory effect[J]? J Clin Endocrinol Metab,2001,86 (12):3257-3265. 被引量：1
9ALJADA A,GHANIM H,MOHANTY P,et al.Insulin inhibits the proinflammatory transcription factor early growth response gene-1 (Egr) -1 expression in mononuclear cells (MNC) and reduces plasma tissue factor(TF) and plasminogen activator inhibitor-1 (PAI-l) concentrations[J].J Clin Endocrinol Metab,2002,87 (3):1419-1422. 被引量：1
10TAKEBAYASHI K,ASO Y,INUKAI T.Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type2 diabetes[J].Metabolism,2004,53 (6):693-699. 被引量：1
2Angulo P. GI epidemiology: nonalcoholic fatty liver disease [ J]. Ali- ment Pharmacol Ther,2007,25 (8) :883 -889. 被引量：1
3Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease[ J]. Nat Rev Immuno1,2011 , 11 ( 2 ) :85 - 97. 被引量：1
4Cusi K. Role of obesity and lipotoxicity in the development of non- alcoholic steatohepatitis(Nash):thophysiology and clinical impli- cations[J].Gastroenteology, 2012,142 ( 4 ) : 711-725. 被引量：1
5Kirbis S, Breskvar UD, Saboevic M, et al. Inflammation markers in patients with coronary artery diseases-comparison of intracoronary and systemic levels[J].Wien Klin Wochenchr,2010,122 (2):31- 34. 被引量：1
